Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,763,923
+$6,359,553 QoQ
Shares Held
69,799
+70.1% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#148
of 768 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
30,741 | $2,544,739 |
All Filings in NBIX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,763,923 | 69,799 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,404,370 | 41,023 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $237,706 | 1,676 | Shares | Sole | 2026-02-13 | |
| 2025-03-31 | $353,477 | 3,196 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,119,707 | 22,855 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,031,553 | 26,311 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,090,312 | 29,711 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,280,622 | 31,037 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,492,561 | 26,507 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,915,775 | 25,918 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,628,329 | 27,872 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,812,296 | 27,784 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,594,595 | 21,723 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||